The economic benefits and costs of COVID-19 mitigation measures in Mexico


  • Rubén Irvin Rojas Valdés Centro de Investigación y Docencia Económicas



COVID-19, Mexico, cost-benefit, epidemic


In this paper I calculate the daily flows of COVID-19 cases under the scenario of social distance and restricted economic activity implemented during the first months after the beginning of the epidemic, and under a counterfactual uncontrolled scenario with no mitigation measures. I estimate that social distance policies reduce the number of COVID-19 cases by 33%, saving over 292,000 lives. The benefits of these measures are monetized as 526 billion USD. Under a plausible economic recovery trajectory, I estimate that the net cost of mitigation in terms of output gap is equal to 35% of Mexico’s 2019 GDP.


Metrics Loading ...


Anderson, R.M., H. Heesterbeek, D. Klinkenberg, and T.D. Hollingsworth. 2020. How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet, 395(10228): 931-934.

Banco de México. 2020. Informe trimestral enero-marzo 2020,

Esquivel, G. 2020. Los impactos económicos de la pandemia en México, Banco de México,

Ferguson, N., D. Laydon, G. Nedjati-Gilani, N. Imai, K. Ainslie, M. Baguelin, S. Bhatia, A. Boonyasiri, Z. Cucunubá, G. Cuomo-Dannenburg, A. Dighe, I. Dorigatti, H. Fu, K. Gaythorpe, W. Green, A. Hamlet, W. Hinsley, L. C Okell, S. Van Elsland, H. Thompson, R. Verity, E. Volz, H. Wang, Y. Wang, P.G. Walker, C. Walters, P. Winskill, C. Whittaker, C.A. Donnelly, S. Riley, and A. Ghani. 2020. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand, Imperial College London.

Gaythorpe, K., N. Imai, G. Cuomo-Dannenburg, M. Baguelin, S. Bhatia, A. Boonyasiri, A. Cori, Z. Cucunubá, A. Dighe, I. Dorigatti, R. FitzJohn, H. Fu, W. Green, A. Hamlet, W. Hinsley, D. Laydon, G. Nedjati-Gilani, L. Okell, S. Riley, H. Thompson, S. Van Elsland, E. Volz, H. Wang, Y. Wang, C. Whittaker, X. Xi, C. Donnelly, A. Ghani, and N. Ferguson. 2020. Report 8: Symptom progression of COVID-19, Imperial College London.

Graff, M., O. Sánchez, D. Moctezuma, E. Téllez, and S. Miranda. 2020. Medición de movilidad usando Facebook, Google y Twitter,

Greenstone, M. and V. Nigam. 2020. Does social distancing matter? Becker Friedman Institute for Economics Working Paper No. 2020-26, University of Chicago.

Guan, W. J., Z. Ni, Y. Hu, W. Liang, C. Ou, J. He, L. Liu, H. Shan, C. Lei, D. Hui, B. Du, L. Li, G. Zeng, K. Yuen, R. Chen, C. Tang, T. Wang, P. Chen, J. Xiang, S. Li, J. Wang, Z. Liang, Y. Peng, L. Wei, Y. Liu, Y. Hu, P. Peng, J. Wang, J. Liu, Z. Chen, G. Li, Z. Zheng, S. Qiu, J. Luo, C. Ye, S. Zhu, and N. Zhong. 2020. Clinical characteristics of coronavirus disease 2019 in China, New England Journal of Medicine, 382(18): 1708-1720.

Guerrieri, V., G. Lorenzoni, L. Straub, and I. Werning. 2020. Macroeconomic implications of COVID-19: Can negative supply shocks cause demand short-ages? NBER Working Paper No. 26918.

Hammitt, J.K. and L.A. Robinson. 2011. The income elasticity of the value per statistical life: Transferring estimates between high and low income populations, Journal of Benefit-Cost Analysis, 2(1): 1-29.

IMF. 2020. World economic outlook. Update: June 2020,

Moghadas, S.M., A. Shoukat, M. Fitzpatrick, C. Wells, P. Sah, A. Pandey, J. Sachs, Z. Wang, L. Meyers, B. Singer, and A. Galvani. 2020. Projecting hospital utilization during the COVID-19 outbreaks in the United States, Proceedings of the National Academy of Sciences, 117(16): 9122-9126.

OECD. 2012. Mortality Risk Valuation in Environment, Health and Transport Policies, Paris, OECD.

OECD. 2019. Hospital beds and discharge rates, in Health at a Glance 2019: OECD Indicators, Paris, OECD.

Quiroga, R., G. González, and D.I. Rodríguez. 2020. Estimaciones del modelo Gompertz para los estados y zonas metropolitanas de México, Proyectos CONACYT,

Robinson, L.A., J. Hammitt, M. Cecchini, K. Chalkidou, K. Claxton, M. Cropper, P. Hoang-Vu, D. Ferranti, A. Deolalikar, F. Guanais, D. Jamison, S. Kwon, J. Lauer, L. O’Keeffe, D. Walker, D. Whittington, T. Wilkinson, D. Wilson, and B. Wong. 2019a. Reference case guidelines for benefit-cost analysis in global health and development, bcaguidelines/.

Robinson, L.A., J.K. Hammitt, and L. O’Keeffe. 2019b. Valuing mortality risk reductions in global benefit-cost analysis, Journal of Benefit-Cost Analysis, 10(S1): 15-50.

Secretaría de Salud. 2020a. Catálogo de clave única de establecimientos de salud (CLUES),

Secretaría de Salud. 2020b. Recursos en salud sectorial 2018,

Thunström, L., S.C. Newbold, D. Finnoff, M. Ashworth, and J.F. Shogren. 2020. The benefits and costs of using social distancing to flatten the curve for COVID-19, Journal of Benefit-Cost Analysis, 11(2): 1-27.

Verity, R., Lu. Okell, I. Dorigatti, P. Winskill, C. Whittaker, N. Imai, G. Cuomo-Dannenburg, H. Thompson, P. Walker, H. Fu, A. Dighe, J. T Griffin, M. Baguelin, S. Bhatia, A. Boonyasiri, A. Cori, Z. Cucunubá, R. FitzJohn, K. Gaythorpe, W. Green, A. Hamlet, W. Hinsley, D. Laydon, G. Nedjati-Gilani, S. Riley, S. Elsland, E. Volz, H. Wang, Y. Wang, X. Xi, C. Donnelly, A. Ghani, N. Ferguson. 2020. Estimates of the severity of COVID-19 disease, The Lancet, 20(6): 669-677.

World Bank. 2020. World Bank open data,

Wu, Z. and J.M. McGoogan. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention, Jama, 323(13): 1239-1242.




How to Cite

Rojas Valdés, R. I. (2021). The economic benefits and costs of COVID-19 mitigation measures in Mexico. Estudios Económicos De El Colegio De México, 36(1), 27–56.